Results for 'Regulatory Affairs'
Browse oncology articles matching Regulatory Affairs — expert analysis, clinical perspectives, and industry updates from across drug development and care delivery. Use the tabs above for podcasts, press releases, partners, and people for the same search.
Leon Rozen
What decision-makers actually do when they can't evaluate reasoning directly
Medical Strategy, Medical Leadership, Medical Affairs
There is a scene most advisory professionals will recognise. A recommendation that took weeks to produce — drawing on regulatory environment, market dynamics, scientific evidence, competitor positioning — gets four minutes in a senior forum. A question or two. A decision. The people in that roo…
Apr 12th • 5 mins read
Leon Rozen
The advice was good. It didn't matter.
Medical Strategy, Medical Leadership, Medical Affairs
There is a particular kind of professional frustration that doesn't have a clean name. It isn't failure — the work was sound. It isn't incompetence. The reasoning was careful, the constraints were weighed, the recommendation was defensible. It is something more specific: the experience of having d…
Apr 12th • 5 mins read
Leon Rozen
Medical Judgment at the Point of Decision
Medical Strategy, Medical Leadership, Medical Affairs
Why Experience Matters in Local Medical and Clinical Leadership
Feb 12th • 5 mins read
Leon Rozen
Launch Readiness Is an Organisational Capability
Medical Strategy, Medical Leadership, Medical Affairs
Why Successful Launches Depend on More Than Plans and Checklists
Feb 12th • 5 mins read
Envision Pharma Group
Medical affairs: The power behind redefining commercialization
Medical affairs commercialization, integrating science in pharma, redefining medical affairs roles, strategic medical affairs leadership, early engagement with payers, pharmaceutical commercialization strategies, upskilling in medical affairs, medical aff
In March 2024, Envision Pharma Group held a Medical Affairs Professional Society (MAPS) Americas roundtable with leaders discussing the role of science in commercialization strategies and the importance of integrating robust scientific understanding into the commercial journey. Envision revisite…
Aug 2nd • 3 mins read
Jamie Riley
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates
hiring, talent demand, job market
As pipelines advance and execution accelerates, pharma and biotech hiring may shift again in 2026, reshaping talent demand.
Feb 4th • 7 mins read